BB1.AU Blinklab Ltd
- Market cap
- AUD 109M
- P/E
- -
- P/B
- 5.61x
- ROE
- -37.0%
- Dividend yield
- -
- Fundamental score
- 0.7/5
Ratios use the latest price and the fiscal year ending Jun 2026.
Is BB1.AU undervalued?
Graham numberThe Graham number of Blinklab Ltd cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Blinklab Ltd fundamental analysis
4 of 21 checks passedROE 0/2
Low return on equity (-37.0%), below 10%.
ROA 1/1
Return on assets (-35.1%) is above the industry median (-35.3%).
Profit Consistency 0/2
Not profitable for at least 3 consecutive years.
Earnings Growth 5Y 0/1
Earnings per share history is shorter than 5 years.
Earnings Acceleration 0/1
Not enough positive earnings history to compare last year's growth with the 5-year average.
Earnings Growth vs Industry 0/1
Last year's EPS growth (-2.9%) is below the industry median (24.9%).
Revenue Growth 0/2
Revenue did not grow over the past 3 years or is not reported.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 0/2
Debt to equity cannot be calculated: debt is not reported or equity is negative.
Debt Trend 0/1
Debt to equity has risen over the past 5 years.
Cash Runway 1/2
Cash covers 1.0 years of the current cash burn.
PE vs Market 0/1
PE is negative or not available.
PE vs Industry 0/1
PE is negative or not available.
PBV 0/1
Price to book (5.6x) is above the industry median (4.0x).
Graham Number 0/1
Graham number needs positive earnings and book value.
PEG 0/1
PEG needs positive PE and positive 5-year earnings growth.
Dividend Yield 0/2
No dividend paid in the last reported year.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 0/1
No dividend, or no profit to pay it from.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
Blinklab Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Blinklab Ltd
BlinkLab Limited focuses on the development and commercialization of intellectual property related to smartphone-based neurobehavioural testing. Its smartphone-based application serves as a device for conducting neurobehavioral evaluations and objective sensorimotor biomarkers, which provides scientific support for future regulatory approval and clinical adoption. The company's application also enables remote and rapid testing to aid research on neurodevelopmental and neurod…
Full company profileBlinklab Ltd financial statements
Blinklab Ltd annual financial statements (AUD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 0.00 | 0.00 | 37.0K | 376K | - |
| Operating Income | -483K | -675K | -1.75M | -5.70M | -8.42M |
| EBITDA | - | -619K | -1.67M | -5.57M | -6.81M |
| Net Income | -485K | -676K | -1.75M | -5.71M | -7.22M |
| EPS | 0.00 | -0.01 | -0.02 | -0.05 | -0.05 |
| Balance Sheet | |||||
| Total Assets | 911K | 370K | 6.87M | 9.67M | 20.6M |
| Total Liabilities | 194K | 329K | 386K | 701K | 1.06M |
| Shareholders' Equity | 717K | 40.7K | 6.48M | 8.97M | 19.5M |
| Cash & Short-term Investments | 617K | 50.1K | 6.02M | 8.71M | 7.88M |
| Cash Flow | |||||
| Operating Cash Flow | -303K | -473K | -1.75M | -4.17M | - |
| Capital Expenditure | 265K | 83.1K | 144K | 136K | 1.30M |
| Free Cash Flow | - | -556K | -1.90M | -4.30M | -7.54M |
| Ratios | |||||
| ROE | -67.7% | -1,661.1% | -27.0% | -63.6% | -37.0% |
| ROA | -53.2% | -182.7% | -25.5% | -59.0% | -35.1% |
| Net Profit Margin | - | - | -4,743.7% | -1,519.7% | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Blinklab Ltd dividends
Blinklab Ltd has not paid dividends in the last 5 fiscal years.
Who owns Blinklab Ltd
- Insiders 33.42%
- Institutions 2.60%
- Public & others 63.99%
- Shares outstanding 176M
- Free float 97.4M
Blinklab Ltd company profile
- Company name
- Blinklab Ltd
- Ticker
- BB1.AU
- ISIN
- AU0000322851
- Exchange
- Australian Securities Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Fiscal year end
- June
- Address
- 216 St Georges Tce, Perth, WA, Australia, 6000
- Phone
- 61 2 9068 1925
- Website
- blinklab.org
About Blinklab Ltd
BlinkLab Limited focuses on the development and commercialization of intellectual property related to smartphone-based neurobehavioural testing. Its smartphone-based application serves as a device for conducting neurobehavioral evaluations and objective sensorimotor biomarkers, which provides scientific support for future regulatory approval and clinical adoption. The company's application also enables remote and rapid testing to aid research on neurodevelopmental and neurodegenerative conditions such as schizophrenia, autism, attention deficit hyperactivity disorder (ADHD), and various forms of dementia. The company was incorporated in 2021 and is based in Perth, Australia.
Blinklab Ltd management
6- Dr. Hendrikus Johannes Boele M.D., Ph.D.Co-Founder, CEO, MD & Director
- Dr. Anton Uvarov BioChem, MBA, MedGen, Ph.D.Co-Founder, COO & Executive Director
- Mr. Cornelis Peter Boele M.A.Co-Founder & CTO
- Dr. Sebastiaan K.E Koekkoek Ph.D.Co-Founder & Chief Quality and Regulatory Officer
- Myrthe Ottenhoff M.D., Ph.D.Chief Medical Officer
- Mr. Christopher Bryan James Achurch B.Com., C.A.Company Secretary